期刊文献+

质量控制对降低维持性血液透析患者心血管并发症的影响

下载PDF
导出
摘要 目的:降低维持性血液透析患者心血管并发症。方法:本研究通过对维持性血液透析患者心血管并发症进行研究分析,设置心血管并发症情况查检表,把握患者并发症现状,拟定对策,制定整改措施,比较实施前后心血管事件发生率。结果:实施8个月后心血管发生率显著低于活动前(P<0.05)。结论:结论:采取质量控制能有效的降低维持性血液透析患者心血管并发症的发生。 Objective : To reduce the cardiovascular complications of maintenance hemodialysis patients: In this study, we investigated the cardiovascular complications of maintenance hemodialysis patients, set the cardiovascular complications checklist, grasp the status of complications of patients,(P <0.05).Conclusion: Quality control can effectively reduce the cardiovascular complications in maintenance hemodialysis patients. The incidence of cardiovascular events was significantly higher than that of patients before maintenance(P <0.05).Conclusion: Quality control can effectively reduce the cardiovascular complications The occurrence of patients to improve the quality of life
出处 《中国妇幼健康研究》 2017年第S3期34-34,共1页 Chinese Journal of Woman and Child Health Research
关键词 质量控制小组 心脑血管并发症 血液透析 Quality control group Cardiovascular complication Hemodialysis
  • 相关文献

参考文献2

二级参考文献21

  • 1侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量:183
  • 2谷伟军,陆菊明,杨国庆,郭清华,窦京涛,母义明,潘长玉.甲钴胺及叶酸治疗对2型糖尿病同型半胱氨酸硫内酯解酶活性和血浆同型半胱氨酸水平的影响[J].中华医学杂志,2007,87(4):256-258. 被引量:22
  • 3Go AS,Chertow GM,Fan D,et al.Chronic kidney disease and the risks of death,cardiovascular events,and hospitalization[J].N Engl J Med,2004,351 (13):1296-1305.
  • 4Cheung AK,Sarnak MJ,Yan S,et al.Cardiac disease in maintenance hemodialysis patients:results of the HEMO study[J].Kidney Int,2004,65(6):2380-2389.
  • 5Foley RN.Clinical epidemiology of cardiac disease in dialysis patients:left ventricular hypertrophy,ischemic heart disease,and cardiac failure[J].Semin Dial,2003,16(2):111-117.
  • 6Herzog CA,Mangrum JM,Passman R.Sudden cardiac death and dialysis patients[J].Semin Dial,2008,21 (4):300-307.
  • 7Madhumathi R,Brian JG,Pereira A.Prospective trials on anemia of chronic disease:the trial to reduce cardiovascular events with aranesp therapy[J].Kidney Int,2003,64(Suppl 87):S12-S19.
  • 8Kraml P,Potockova J,Koprivova H,et al.Ferritin,oxidative stress and coronary atherosclerosis[J].Nitr Lek,2004,50(2):197-202.
  • 9You SA,Wang Q.Ferritin in atherosclerosis[J].Clin Chim Acta,2005,357(1):1-16.
  • 10Kerr PG,Guerin AP.Arterial calcification and stiffness in chronic kidney disease[J].Clin Exp Pharmacol Physiol,2007,34 (7):683-687.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部